Close Asset Management’s Novartis NVS Stock Holding History

Close Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-200	Closed	-$28K	–	287
2025 Q4	$28K	Hold	200	–	–	﹤0.01%	199
2025 Q3	$26K	Hold	200	–	–	﹤0.01%	204
2025 Q2	$24K	Hold	200	–	–	﹤0.01%	197
2025 Q1	$22K	Hold	200	–	–	﹤0.01%	188
2024 Q4	$19K	Hold	200	–	–	﹤0.01%	197
2024 Q3	$23K	Hold	200	–	–	﹤0.01%	195
2024 Q2	$21K	Hold	200	–	–	﹤0.01%	197
2024 Q1	$19K	Hold	200	–	–	﹤0.01%	197
2023 Q4	$20K	Hold	200	–	–	﹤0.01%	182
2023 Q3	$20K	Hold	200	–	–	﹤0.01%	175
2023 Q2	$20K	Hold	200	–	–	﹤0.01%	194
2023 Q1	$18K	Hold	200	–	–	﹤0.01%	185
2022 Q4	$18K	Hold	200	–	–	﹤0.01%	155
2022 Q3	$15K	Hold	200	–	–	﹤0.01%	147
2022 Q2	$17K	Hold	200	–	–	﹤0.01%	145
2022 Q1	$17K	Hold	200	–	–	﹤0.01%	175
2021 Q4	$17K	Hold	200	–	–	﹤0.01%	175
2021 Q3	$16K	Hold	200	–	–	﹤0.01%	176
2021 Q2	$18K	Hold	200	–	–	﹤0.01%	159
2021 Q1	$17K	Buy	+200	New	+$17.9K	﹤0.01%	165
2019 Q2	–	Sell	-223	Closed	-$19K	–	191
2019 Q1	$19K	Buy	+223	New	+$17.9K	﹤0.01%	156

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Close Asset Management's NVS Position: Q1 2026 in Review

Close Asset Management sold out of Novartis (NVS) in Q1 2026, closing a stake of 200 shares — an estimated $28K sold.

Close Asset Management first reported a position in NVS in Q1 2019 and held it in 21 quarters. The position peaked at $28K in Q4 2025. 1,604 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Close Asset Management reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
Close Asset Management sold 200 Novartis shares in Q1 2026, an estimated $28K.
Close Asset Management first reported a position in Novartis in Q1 2019 and held it in 21 quarters.
Close Asset Management's Novartis position peaked at $28K in Q4 2025.
1,604 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Close Asset Management's 13F filing for Q1 2026, filed 12 May 2026.